Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/55660
Title: Acute effects of hydroxychloroquine prophylaxis for COVID-19 in health care professionals – An online survey
Authors: Dalai, Chanchal Kumar
Sarkar, Deblina
Ghosh, Abhishek
Ahmed, Shah Newaz
Das, Subir Kumar
Roy, Suman Kumar
Mukhopadhyay, Keshab
Keywords: Hydroxychloroquine;Ondansetron;Prophylaxis;Systemic lupus erythematous
Issue Date: Dec-2020
Publisher: NISCAIR-CSIR, India
Abstract: Hydroxychloroquine, an antimalarial, is being used worldwide for prophylaxis and treatment of Corona virus disease-19 (COVID-19). Though the drug is commonly used in many chronic inflammatory diseases for protracted periods, its safety in the new indication is still under scrutiny. Therefore, this institute based study sought to assess the acute adverse effects of hydroxychloroquine among in-house health care professionals who were taking the drug for COVID-19 prophylaxis. A questionnaire seeking information on the use of the drug was prepared and disseminated electronically to the target population. The responses were also received electronically and analysed. The participants (n=54) had taken prophylaxis for 1-7 weeks. The most common adverse effects in the cohort were nausea (02) and skin rash (02). The total number of adverse effects reported by the participants was 08. One incidence each of gastric upset (01), dizziness (01), pain abdomen (01), and chest tightness (01) was reported. None of the adverse effects were serious. Our study indicates that the prophylactic weekly single dose of hydroxychloroquine is not associated with any serious adverse effects within 1-7 weeks of initiation. Elucidation of the long term and chronic adverse effects, if any, requires further studies.
Page(s): 707-712
URI: http://nopr.niscair.res.in/handle/123456789/55660
ISSN: 0975-0959 (Online); 0301-1208 (Print)
Appears in Collections:IJBB Vol.57(6) [December 2020]

Files in This Item:
File Description SizeFormat 
IJBB 57(6) 707-712.pdf489.4 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.